Larry Leksell, grundare och ordförande, Elekta
Summary
Larry Lixell, founder and chairman of Elekta, discusses the company's origins, its pivot from neurosurgery to broader cancer care, and current market challenges. He addresses heavy short-selling, attributing it to post-pandemic inflation, component shortages, and a temporary loss of market share in the US due to technological gaps. Lixell also analyzes the complex dynamics of the Chinese market, emphasizing the need for local integration and partnerships to compete with domestic rivals. Finally, he reflects on Elekta's financial strategy, including high dividends and the possibility of a fu…
Listen ad-free on Castria